ADVANCED BIOMEDICAL RESEARCH, Inc.

 ABR is a full-service, Phase I-IV global CRO dedicated to meeting the needs of pharmaceutical, biotechnology, and medical device companies. ABR offers an extensive range of clinical services including clinical study design, strategic and regulatory consulting, project management, monitoring, clinical data management, biostatistics, pharmacokinetic and pharmacodynamic analysis, quality assurance auditing, medical writing, pharmacovigilance and regulatory submissions.

ABR’s clinical research professionals have a successful track record of executing and managing Phase II-IV multicenter trials in North America, Europe and Asia, and our accomplished team has been involved in more than 400 clinical trials since 1994.

ABR tests innovator and generic compounds in its state-of-the-art 72-bed Phase I-II clinical research facilities in New Jersey and performs a wide range of clinical trials including first-in-human, dose escalation, proof of concept, bioavailability, bioequivalence, PK/PD, fed-fasted, drug-drug and drug-alcohol interactions and thorough or definitive QTc evaluations.

Copyright © 2000-2007 Advanced Biomedical Research, Inc. All rights reserved.